E
CV Sciences, Inc.
CVSI
$0.0341
-$0.0019-5.28%
E
Sell
9/18/2024Downgrade
CV Sciences, Inc. (CVSI) was downgraded to E+ from D- on 9/18/2024 due to a decline in the volatility index and total return index.
CV Sciences, Inc. (CVSI) was downgraded to E+ from D- on 9/18/2024 due to a decline in the volatility index and total return index.
D
Sell
9/3/2024Upgraded
CV Sciences, Inc. (CVSI) was upgraded to D- from E+ on 9/3/2024 due to an increase in the volatility index.
CV Sciences, Inc. (CVSI) was upgraded to D- from E+ on 9/3/2024 due to an increase in the volatility index.
E
Sell
8/19/2024Downgrade
CV Sciences, Inc. (CVSI) was downgraded to E+ from D- on 8/19/2024 due to a large decline in the growth index, volatility index and valuation index. Total revenue declined 1.2% from $4M to $3.95M.
CV Sciences, Inc. (CVSI) was downgraded to E+ from D- on 8/19/2024 due to a large decline in the growth index, volatility index and valuation index. Total revenue declined 1.2% from $4M to $3.95M.
D
Sell
7/22/2024Upgraded
CV Sciences, Inc. (CVSI) was upgraded to D- from E+ on 7/22/2024 due to a large increase in the total return index, valuation index and volatility index.
CV Sciences, Inc. (CVSI) was upgraded to D- from E+ on 7/22/2024 due to a large increase in the total return index, valuation index and volatility index.
E
Sell
6/5/2024Downgrade
CV Sciences, Inc. (CVSI) was downgraded to E+ from D+ on 6/5/2024 due to a significant decline in the valuation index, efficiency index and solvency index. The quick ratio declined from 0.29 to 0.2, and total capital declined 21.2% from $3.35M to $2.64M.
CV Sciences, Inc. (CVSI) was downgraded to E+ from D+ on 6/5/2024 due to a significant decline in the valuation index, efficiency index and solvency index. The quick ratio declined from 0.29 to 0.2, and total capital declined 21.2% from $3.35M to $2.64M.
D
Sell
4/11/2024Downgrade
CV Sciences, Inc. (CVSI) was downgraded to D+ from C- on 4/11/2024 due to a large decline in the growth index and volatility index. Operating cash flow declined 500% from -$19 to -$114, earnings per share declined from -$0.0029 to -$0.0057, and EBIT declined 46% from -$437 to -$638.
CV Sciences, Inc. (CVSI) was downgraded to D+ from C- on 4/11/2024 due to a large decline in the growth index and volatility index. Operating cash flow declined 500% from -$19 to -$114, earnings per share declined from -$0.0029 to -$0.0057, and EBIT declined 46% from -$437 to -$638.
C
Hold
4/1/2024Upgraded
CV Sciences, Inc. (CVSI) was upgraded to C- from D+ on 4/1/2024 due to an increase in the total return index and volatility index.
CV Sciences, Inc. (CVSI) was upgraded to C- from D+ on 4/1/2024 due to an increase in the total return index and volatility index.
D
Sell
3/11/2024Downgrade
CV Sciences, Inc. (CVSI) was downgraded to D+ from C- on 3/11/2024 due to a decline in the total return index and volatility index.
CV Sciences, Inc. (CVSI) was downgraded to D+ from C- on 3/11/2024 due to a decline in the total return index and volatility index.
C
Hold
2/23/2024Upgraded
CV Sciences, Inc. (CVSI) was upgraded to C- from D+ on 2/23/2024 due to an increase in the volatility index and total return index.
CV Sciences, Inc. (CVSI) was upgraded to C- from D+ on 2/23/2024 due to an increase in the volatility index and total return index.
D
Sell
2/2/2024Downgrade
CV Sciences, Inc. (CVSI) was downgraded to D+ from C- on 2/2/2024 due to a decline in the volatility index, efficiency index and growth index.
CV Sciences, Inc. (CVSI) was downgraded to D+ from C- on 2/2/2024 due to a decline in the volatility index, efficiency index and growth index.
C
Hold
1/18/2024Upgraded
CV Sciences, Inc. (CVSI) was upgraded to C- from D+ on 1/18/2024 due to an increase in the volatility index and total return index.
CV Sciences, Inc. (CVSI) was upgraded to C- from D+ on 1/18/2024 due to an increase in the volatility index and total return index.
D
Sell
12/27/2023Downgrade
CV Sciences, Inc. (CVSI) was downgraded to D+ from C- on 12/27/2023 due to a decline in the volatility index.
CV Sciences, Inc. (CVSI) was downgraded to D+ from C- on 12/27/2023 due to a decline in the volatility index.
C
Hold
12/11/2023Upgraded
CV Sciences, Inc. (CVSI) was upgraded to C- from D+ on 12/11/2023 due to an increase in the volatility index and total return index.
CV Sciences, Inc. (CVSI) was upgraded to C- from D+ on 12/11/2023 due to an increase in the volatility index and total return index.
D
Sell
11/20/2023Upgraded
CV Sciences, Inc. (CVSI) was upgraded to D+ from D on 11/20/2023 due to a significant increase in the valuation index, growth index and efficiency index. Earnings per share increased from -$0.01 to -$0.0029, net income increased 65.3% from -$1.29M to -$447, and EBIT increased 59.39% from -$1.08M to -$437.
CV Sciences, Inc. (CVSI) was upgraded to D+ from D on 11/20/2023 due to a significant increase in the valuation index, growth index and efficiency index. Earnings per share increased from -$0.01 to -$0.0029, net income increased 65.3% from -$1.29M to -$447, and EBIT increased 59.39% from -$1.08M to -$437.
D
Sell
8/15/2023Upgraded
CV Sciences, Inc. (CVSI) was upgraded to D from E+ on 8/15/2023 due to a significant increase in the efficiency index, total return index and solvency index. The quick ratio increased from 0.22 to 0.39, and debt to equity declined from 0.11 to 0.04.
CV Sciences, Inc. (CVSI) was upgraded to D from E+ on 8/15/2023 due to a significant increase in the efficiency index, total return index and solvency index. The quick ratio increased from 0.22 to 0.39, and debt to equity declined from 0.11 to 0.04.
E
Sell
3/14/2023Downgrade
CV Sciences, Inc. (CVSI) was downgraded to E+ from D- on 3/14/2023 due to a decline in the volatility index.
CV Sciences, Inc. (CVSI) was downgraded to E+ from D- on 3/14/2023 due to a decline in the volatility index.
D
Sell
2/27/2023Downgrade
CV Sciences, Inc. (CVSI) was downgraded to D- from D on 2/27/2023 due to a decline in the volatility index and valuation index.
CV Sciences, Inc. (CVSI) was downgraded to D- from D on 2/27/2023 due to a decline in the volatility index and valuation index.
D
Sell
2/9/2023Upgraded
CV Sciences, Inc. (CVSI) was upgraded to D from E+ on 2/9/2023 due to an increase in the volatility index.
CV Sciences, Inc. (CVSI) was upgraded to D from E+ on 2/9/2023 due to an increase in the volatility index.
E
Sell
2/8/2023Downgrade
CV Sciences, Inc. (CVSI) was downgraded to E+ from D on 2/8/2023 due to a decline in the valuation index and volatility index.
CV Sciences, Inc. (CVSI) was downgraded to E+ from D on 2/8/2023 due to a decline in the valuation index and volatility index.
D
Sell
1/4/2023Upgraded
CV Sciences, Inc. (CVSI) was upgraded to D from D- on 1/4/2023 due to an increase in the volatility index.
CV Sciences, Inc. (CVSI) was upgraded to D from D- on 1/4/2023 due to an increase in the volatility index.
D
Sell
12/15/2022Downgrade
CV Sciences, Inc. (CVSI) was downgraded to D- from D on 12/15/2022 due to a decline in the volatility index and total return index.
CV Sciences, Inc. (CVSI) was downgraded to D- from D on 12/15/2022 due to a decline in the volatility index and total return index.
D
Sell
11/21/2022Upgraded
CV Sciences, Inc. (CVSI) was upgraded to D from D- on 11/21/2022 due to an increase in the growth index, volatility index and total return index. Earnings per share increased from -$0.03 to -$0.007, operating cash flow increased 53.21% from -$1.17M to -$547, and EBIT increased 38.88% from -$2.32M to -$1.42M.
CV Sciences, Inc. (CVSI) was upgraded to D from D- on 11/21/2022 due to an increase in the growth index, volatility index and total return index. Earnings per share increased from -$0.03 to -$0.007, operating cash flow increased 53.21% from -$1.17M to -$547, and EBIT increased 38.88% from -$2.32M to -$1.42M.
D
Sell
11/7/2022Downgrade
CV Sciences, Inc. (CVSI) was downgraded to D- from D on 11/7/2022 due to a decline in the volatility index.
CV Sciences, Inc. (CVSI) was downgraded to D- from D on 11/7/2022 due to a decline in the volatility index.
D
Sell
10/21/2022Upgraded
CV Sciences, Inc. (CVSI) was upgraded to D from D- on 10/21/2022 due to an increase in the volatility index and total return index.
CV Sciences, Inc. (CVSI) was upgraded to D from D- on 10/21/2022 due to an increase in the volatility index and total return index.
D
Sell
10/3/2022Downgrade
CV Sciences, Inc. (CVSI) was downgraded to D- from D on 10/3/2022 due to a decline in the volatility index.
CV Sciences, Inc. (CVSI) was downgraded to D- from D on 10/3/2022 due to a decline in the volatility index.
D
Sell
9/9/2022Upgraded
CV Sciences, Inc. (CVSI) was upgraded to D from D- on 9/9/2022 due to an increase in the volatility index.
CV Sciences, Inc. (CVSI) was upgraded to D from D- on 9/9/2022 due to an increase in the volatility index.
D
Sell
8/22/2022Downgrade
CV Sciences, Inc. (CVSI) was downgraded to D- from D on 8/22/2022 due to a decline in the growth index, volatility index and solvency index. Operating cash flow declined 208.44% from -$379 to -$1.17M, debt to equity increased from 0.33 to 0.61, and earnings per share declined from -$0.02 to -$0.03.
CV Sciences, Inc. (CVSI) was downgraded to D- from D on 8/22/2022 due to a decline in the growth index, volatility index and solvency index. Operating cash flow declined 208.44% from -$379 to -$1.17M, debt to equity increased from 0.33 to 0.61, and earnings per share declined from -$0.02 to -$0.03.
D
Sell
5/19/2022Upgraded
CV Sciences, Inc. (CVSI) was upgraded to D from D- on 5/19/2022 due to a major increase in the growth index. Earnings per share increased from -$0.0805 to -$0.02, operating cash flow increased 67.44% from -$1.16M to -$379, and EBIT increased 60.33% from -$8.84M to -$3.51M.
CV Sciences, Inc. (CVSI) was upgraded to D from D- on 5/19/2022 due to a major increase in the growth index. Earnings per share increased from -$0.0805 to -$0.02, operating cash flow increased 67.44% from -$1.16M to -$379, and EBIT increased 60.33% from -$8.84M to -$3.51M.
D
Sell
5/5/2022Upgraded
CV Sciences, Inc. (CVSI) was upgraded to D- from E+ on 05/05/2022.
CV Sciences, Inc. (CVSI) was upgraded to D- from E+ on 05/05/2022.
E
Sell
4/20/2022Downgrade
CV Sciences, Inc. (CVSI) was downgraded to E+ from D- on 4/20/2022 due to a decline in the total return index and volatility index.
CV Sciences, Inc. (CVSI) was downgraded to E+ from D- on 4/20/2022 due to a decline in the total return index and volatility index.
D
Sell
4/18/2022Downgrade
CV Sciences, Inc. (CVSI) was downgraded to D- from D on 4/18/2022 due to a major decline in the growth index, total return index and volatility index. Earnings per share declined from -$0.0004 to -$0.0805, EBIT declined 196.74% from -$2.98M to -$8.84M, and total revenue declined 2.7% from $5.11M to $4.97M.
CV Sciences, Inc. (CVSI) was downgraded to D- from D on 4/18/2022 due to a major decline in the growth index, total return index and volatility index. Earnings per share declined from -$0.0004 to -$0.0805, EBIT declined 196.74% from -$2.98M to -$8.84M, and total revenue declined 2.7% from $5.11M to $4.97M.
D
Sell
11/22/2021Upgraded
CV Sciences, Inc. (CVSI) was upgraded to D from E+ on 11/22/2021 due to a large increase in the growth index. Earnings per share increased from -$0.0328 to -$0.0004, operating cash flow increased 48.83% from -$3.06M to -$1.57M, and EBIT increased 15.1% from -$3.51M to -$2.98M.
CV Sciences, Inc. (CVSI) was upgraded to D from E+ on 11/22/2021 due to a large increase in the growth index. Earnings per share increased from -$0.0328 to -$0.0004, operating cash flow increased 48.83% from -$3.06M to -$1.57M, and EBIT increased 15.1% from -$3.51M to -$2.98M.
E
Sell
11/8/2021Downgrade
CV Sciences, Inc. (CVSI) was downgraded to E+ from D- on 11/8/2021 due to a noticeable decline in the total return index, volatility index and solvency index. The quick ratio declined from 0.41 to 0.25, and debt to equity increased from 0.33 to 0.37.
CV Sciences, Inc. (CVSI) was downgraded to E+ from D- on 11/8/2021 due to a noticeable decline in the total return index, volatility index and solvency index. The quick ratio declined from 0.41 to 0.25, and debt to equity increased from 0.33 to 0.37.
D
Sell
5/6/2021Downgrade
CV Sciences, Inc. (CVSI) was downgraded to D- from D on 5/6/2021 due to a significant decline in the solvency index, total return index and growth index. EBIT declined 200.35% from -$3.15M to -$9.46M, earnings per share declined from -$0.0316 to -$0.0928, and debt to equity increased from 0.18 to 0.38.
CV Sciences, Inc. (CVSI) was downgraded to D- from D on 5/6/2021 due to a significant decline in the solvency index, total return index and growth index. EBIT declined 200.35% from -$3.15M to -$9.46M, earnings per share declined from -$0.0316 to -$0.0928, and debt to equity increased from 0.18 to 0.38.
D
Sell
5/20/2019Downgrade
CV Sciences, Inc. (CVSI) was downgraded to D from C on 5/20/2019 due to a major decline in the growth index, efficiency index and valuation index. Earnings per share declined from $0.0291 to -$0.1, EBIT declined 440.23% from $2.76M to -$9.38M, and net income declined 423.5% from $2.9M to -$9.38M.
CV Sciences, Inc. (CVSI) was downgraded to D from C on 5/20/2019 due to a major decline in the growth index, efficiency index and valuation index. Earnings per share declined from $0.0291 to -$0.1, EBIT declined 440.23% from $2.76M to -$9.38M, and net income declined 423.5% from $2.9M to -$9.38M.
C
Hold
3/29/2019Upgraded
CV Sciences, Inc. (CVSI) was upgraded to C from C- on 3/29/2019 due to a noticeable increase in the total return index, valuation index and volatility index.
CV Sciences, Inc. (CVSI) was upgraded to C from C- on 3/29/2019 due to a noticeable increase in the total return index, valuation index and volatility index.
C
Hold
2/6/2019Downgrade
CV Sciences, Inc. (CVSI) was downgraded to C- from C on 2/6/2019 due to a significant decline in the total return index, growth index and efficiency index.
CV Sciences, Inc. (CVSI) was downgraded to C- from C on 2/6/2019 due to a significant decline in the total return index, growth index and efficiency index.
C
Hold
8/2/2018Upgraded
CV Sciences, Inc. (CVSI) was upgraded to C from D on 8/2/2018 due to a significant increase in the total return index, solvency index and efficiency index. Net income increased 414.44% from $619.3 to $3.19M, debt to equity declined from 0.07 to 0.04, and the quick ratio increased from 2.26 to 3.
CV Sciences, Inc. (CVSI) was upgraded to C from D on 8/2/2018 due to a significant increase in the total return index, solvency index and efficiency index. Net income increased 414.44% from $619.3 to $3.19M, debt to equity declined from 0.07 to 0.04, and the quick ratio increased from 2.26 to 3.
D
Sell
4/2/2018Upgraded
CV Sciences, Inc. (CVSI) was upgraded to D from D- on 4/2/2018 due to a significant increase in the total return index, volatility index and growth index. Operating cash flow increased 570.08% from $442.9 to $2.97M, earnings per share increased from -$0.0067 to $0.0052, and EBIT increased 165.77% from -$492.8 to $324.1.
CV Sciences, Inc. (CVSI) was upgraded to D from D- on 4/2/2018 due to a significant increase in the total return index, volatility index and growth index. Operating cash flow increased 570.08% from $442.9 to $2.97M, earnings per share increased from -$0.0067 to $0.0052, and EBIT increased 165.77% from -$492.8 to $324.1.
D
Sell
11/2/2016Downgrade
CV Sciences, Inc. (CVSI) was downgraded to D- from D on 11/2/2016 due to a decline in the efficiency index, solvency index and volatility index. The quick ratio declined from 0.76 to 0.53, debt to equity increased from 0.11 to 0.13, and total capital declined 4.05% from $24.15M to $23.18M.
CV Sciences, Inc. (CVSI) was downgraded to D- from D on 11/2/2016 due to a decline in the efficiency index, solvency index and volatility index. The quick ratio declined from 0.76 to 0.53, debt to equity increased from 0.11 to 0.13, and total capital declined 4.05% from $24.15M to $23.18M.
D
Sell
10/31/2016Upgraded
CV Sciences, Inc. (CVSI) was upgraded to D from D- on 10/31/2016 due to an increase in the volatility index, solvency index and total return index.
CV Sciences, Inc. (CVSI) was upgraded to D from D- on 10/31/2016 due to an increase in the volatility index, solvency index and total return index.
D
Sell
8/12/2016Downgrade
CV Sciences, Inc. (CVSI) was downgraded to D- from D on 8/12/2016 due to a large decline in the growth index, total return index and solvency index. Operating cash flow declined 606.5% from -$112.3 to -$793.4, debt to equity increased from 0.03 to 0.11, and EBIT declined 71.14% from -$1.21M to -$2.06M.
CV Sciences, Inc. (CVSI) was downgraded to D- from D on 8/12/2016 due to a large decline in the growth index, total return index and solvency index. Operating cash flow declined 606.5% from -$112.3 to -$793.4, debt to equity increased from 0.03 to 0.11, and EBIT declined 71.14% from -$1.21M to -$2.06M.
D
Sell
5/18/2016Upgraded
CV Sciences, Inc. (CANV) was upgraded to D from D- on 5/18/2016 due to a substantial increase in the growth index, efficiency index and total return index. Operating cash flow increased 91.25% from -$1.28M to -$112.3, earnings per share increased from -$0.182 to -$0.0307, and net income increased 76.74% from -$6.59M to -$1.53M.
CV Sciences, Inc. (CANV) was upgraded to D from D- on 5/18/2016 due to a substantial increase in the growth index, efficiency index and total return index. Operating cash flow increased 91.25% from -$1.28M to -$112.3, earnings per share increased from -$0.182 to -$0.0307, and net income increased 76.74% from -$6.59M to -$1.53M.
D
Sell
5/13/2016Downgrade
CV Sciences, Inc. (CANV) was downgraded to D- from D on 5/13/2016 due to a large decline in the solvency index, growth index and volatility index. Earnings per share declined from -$0.0284 to -$0.182, operating cash flow declined 242.35% from $902.1 to -$1.28M, and EBIT declined 80.08% from -$1.66M to -$2.99M.
CV Sciences, Inc. (CANV) was downgraded to D- from D on 5/13/2016 due to a large decline in the solvency index, growth index and volatility index. Earnings per share declined from -$0.0284 to -$0.182, operating cash flow declined 242.35% from $902.1 to -$1.28M, and EBIT declined 80.08% from -$1.66M to -$2.99M.
D
Sell
3/14/2016Downgrade
CV Sciences, Inc. (CANV) was downgraded to D from D+ on 3/14/2016 due to a significant decline in the volatility index, total return index and valuation index.
CV Sciences, Inc. (CANV) was downgraded to D from D+ on 3/14/2016 due to a significant decline in the volatility index, total return index and valuation index.
D
Sell
2/26/2016Upgraded
CV Sciences, Inc. (CANV) was upgraded to D+ from D on 2/26/2016 due to a noticeable increase in the volatility index and valuation index.
CV Sciences, Inc. (CANV) was upgraded to D+ from D on 2/26/2016 due to a noticeable increase in the volatility index and valuation index.
D
Sell
11/24/2015Downgrade
CannaVEST Corp. (CANV) was downgraded to D from D+ on 11/24/2015 due to a large decline in the volatility index and efficiency index. Net income declined 50.6% from -$2M to -$989.5.
CannaVEST Corp. (CANV) was downgraded to D from D+ on 11/24/2015 due to a large decline in the volatility index and efficiency index. Net income declined 50.6% from -$2M to -$989.5.
D
Sell
9/8/2015Upgraded
CannaVEST Corp. (CANV) was upgraded to D+ from D on 9/8/2015 due to a substantial increase in the volatility index.
CannaVEST Corp. (CANV) was upgraded to D+ from D on 9/8/2015 due to a substantial increase in the volatility index.
D
Sell
8/24/2015Downgrade
CannaVEST Corp. (CANV) was downgraded to D from D+ on 8/24/2015 due to a noticeable decline in the volatility index.
CannaVEST Corp. (CANV) was downgraded to D from D+ on 8/24/2015 due to a noticeable decline in the volatility index.
D
Sell
8/17/2015Downgrade
CannaVEST Corp. (CANV) was downgraded to D+ from C- on 8/17/2015 due to a large decline in the efficiency index, volatility index and growth index. Operating cash flow declined 51.86% from -$2.58M to -$1.24M, EBIT declined 25.7% from -$2.69M to -$2M, and net income declined 24.38% from -$2.65M to -$2M.
CannaVEST Corp. (CANV) was downgraded to D+ from C- on 8/17/2015 due to a large decline in the efficiency index, volatility index and growth index. Operating cash flow declined 51.86% from -$2.58M to -$1.24M, EBIT declined 25.7% from -$2.69M to -$2M, and net income declined 24.38% from -$2.65M to -$2M.
C
Hold
5/15/2015Upgraded
CannaVEST Corp. (CANV) was upgraded to C- from D+ on 5/15/2015 due to a major increase in the efficiency index, growth index and valuation index. Operating cash flow increased 105.91% from -$1.25M to -$2.58M, total capital increased 8.14% from $21.08M to $22.79M, and total revenue increased 0.78% from $2.69M to $2.71M.
CannaVEST Corp. (CANV) was upgraded to C- from D+ on 5/15/2015 due to a major increase in the efficiency index, growth index and valuation index. Operating cash flow increased 105.91% from -$1.25M to -$2.58M, total capital increased 8.14% from $21.08M to $22.79M, and total revenue increased 0.78% from $2.69M to $2.71M.
D
Sell
3/31/2015Downgrade
CannaVEST Corp. (CANV) was downgraded to D+ from B on 3/31/2015 due to a significant decline in the valuation index, efficiency index and growth index. Operating cash flow declined 71.65% from -$4.42M to -$1.25M, and total capital declined 3.82% from $21.91M to $21.08M.
CannaVEST Corp. (CANV) was downgraded to D+ from B on 3/31/2015 due to a significant decline in the valuation index, efficiency index and growth index. Operating cash flow declined 71.65% from -$4.42M to -$1.25M, and total capital declined 3.82% from $21.91M to $21.08M.
B
Buy
9/2/2014Upgraded
CannaVEST Corp. (CANV) was upgraded to B from B- on 9/2/2014 due to an increase in the valuation index and solvency index.
CannaVEST Corp. (CANV) was upgraded to B from B- on 9/2/2014 due to an increase in the valuation index and solvency index.
B
Buy
6/2/2014Upgraded
CannaVEST Corp. (CANV) was upgraded to B- from C on 6/2/2014 due to a significant increase in the efficiency index, valuation index and solvency index. The quick ratio increased from 8.69 to 38.29, debt to equity declined from 0.66 to 0, and total capital increased 55.26% from $13.81M to $21.44M.
CannaVEST Corp. (CANV) was upgraded to B- from C on 6/2/2014 due to a significant increase in the efficiency index, valuation index and solvency index. The quick ratio increased from 8.69 to 38.29, debt to equity declined from 0.66 to 0, and total capital increased 55.26% from $13.81M to $21.44M.
C
Hold
4/28/2014Upgraded
CannaVEST Corp. (CANV) was upgraded to C from D+ on 4/28/2014 due to a significant increase in the valuation index, growth index and efficiency index.
CannaVEST Corp. (CANV) was upgraded to C from D+ on 4/28/2014 due to a significant increase in the valuation index, growth index and efficiency index.
D
Sell
4/17/2014Downgrade
CannaVEST Corp. (CANV) was downgraded to D+ from C- on 4/17/2014 due to a large decline in the total return index and valuation index.
CannaVEST Corp. (CANV) was downgraded to D+ from C- on 4/17/2014 due to a large decline in the total return index and valuation index.
C
Hold
3/6/2014Downgrade
CannaVEST Corp. (CANV) was downgraded to C- from C on 3/6/2014 due to a significant decline in the efficiency index and valuation index.
CannaVEST Corp. (CANV) was downgraded to C- from C on 3/6/2014 due to a significant decline in the efficiency index and valuation index.
OTC PK
03/10/2025 9:30AM Eastern
Quotes delayed
